9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile
C49H27N7 — CID 155217487
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile
9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile (PubChem CID 155217487) has the molecular formula C49H27N7 and a molecular weight of 713.80 g/mol. Its IUPAC name is 9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile.
Molecular Properties
| Compound Name | 9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile |
|---|---|
| PubChem CID | 155217487 |
| Molecular Formula | C49H27N7 |
| Molecular Weight | 713.80 g/mol |
| Exact Mass | 713.23 |
| IUPAC Name | 9-[2-cyano-3-(3-cyanocarbazol-9-yl)-5-(4,6-diphenylpyrimidin-2-yl)phenyl]carbazole-3-carbonitrile |
| SMILES | N#Cc1ccc2c(c1)c1ccccc1n2-c1cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc(-n2c3ccccc3c3cc(C#N)ccc32)c1C#N |
| InChI | InChI=1S/C49H27N7/c50-28-31-19-21-45-38(23-31)36-15-7-9-17-43(36)55(45)47-25-35(49-53-41(33-11-3-1-4-12-33)27-42(54-49)34-13-5-2-6-14-34)26-48(40(47)30-52)56-44-18-10-8-16-37(44)39-24-32(29-51)20-22-46(39)56/h1-27H |
| InChIKey | WTAHZUASYDWPQK-UHFFFAOYSA-N |
| XLogP | 11.29 |
| TPSA | 107.01 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 713.80 |
| LogP ≤ 5 | 11.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155217487 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.